candoxatril

Known as: 3-(1-((4-carboxycyclohexyl)carbamoyl)cyclopentyl)-2-(2-methoxyethoxymethyl)propanoic acid 5-indanyl ester 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2016
024619912016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
AIMS To compare the effects on exercise capacity of the neutral endopeptidase inhibitor candoxatril, and the angiotensin… (More)
Is this relevant?
1999
1999
Candoxatril (UK-79300) is the orally-active prodrug of candoxatrilat (UK-73967), the active enantiomer of (+/-)candoxatrilat (UK… (More)
Is this relevant?
1999
1999
OBJECTIVES The study aimed to assess the hemodynamic and neuroendocrine effects of candoxatril and frusemide compared with… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1998
1998
AIMS To assess the effect of candoxatril, a novel neutral endopeptidase inhibitor, on exercise capacity, clinical status and… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1997
1997
AIMS Candoxatril is a specific neutral endopeptidase (NEP) 24.11 inhibitor, and previous work has documented the effect of NEP… (More)
Is this relevant?
1997
1997
1. Candoxatrilat, an active neutral endopeptidase inhibitor, was released rapidly from the inactive prodrug candoxatril in vivo… (More)
Is this relevant?
1995
1995
The purpose of these experiments was to compare the effects of endopeptidase inhibition with oral candoxatril on systemic and… (More)
Is this relevant?
1992
1992
OBJECTIVE To examine the efficacy and tolerability of the neutral endopeptidase inhibitor, candoxatril (UK 79,300) as monotherapy… (More)
Is this relevant?
1992
1992
Candoxatril is a novel, orally active inhibitor of neutral endopeptidase EC 3.4.24.11, the enzyme that degrades atrial… (More)
Is this relevant?
1992
1992
OBJECTIVE Candoxatril (UK79,300) is an orally available inhibitor of the neutral endopeptidase (E.C.3.4.24.11) which degrades… (More)
Is this relevant?